Clinical Trial

TransitionCHF Systolic Dysfunction to Congestive Heart Failure Cohort Study

Study acronym: TransitionCHF
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
TransitionCHF aims to recruit a unique cohort of patients with asymptomatic left ventricular dysfunction (NYHA I) to study the progression to symptomatic (\>NYHA I) HF and to identify parameters/ biomarkers promoting and predicting the individual risk of transition. Results from TransitionCHF Cohort Study will inform and refine current treatment guidelines. The implementation of common patient data sets and biobanking standards will enable data and biomaterial sharing with other study groups of the German Center for Cardiovascular Research (DZHK). This study will set the standard for a unique DZHK heart failure database and Biobank for innovative preclinical and clinical trials.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2014-12-18; most recent amendment 2023-11-21.
Status change: Recruiting → Active, Not Recruiting 2023-11-21
Trial Details
NCT Number NCT02323750
Lead Sponsor University of Göttingen
Collaborators: University Medical Center Goettingen, Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
Conditions Systolic Dysfunction, Transition, Heart Failure, Biobank
Enrollment 1,000 participants
Start Date 2014-12-01
Primary Completion 2027-09-30 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2023-11-22